NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for RBKB yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS at or above $0.2 in 2026 | A primary condition in Rhinebeck Bancorp, Inc.'s published investment case. The stated target is >=0.2 USD per share. | Intact | EPS falls below $0.2 in FY26 | Diluted EPS: $0.24 per share FY2026-Q2; GAAP. Published target: >=0.2 USD per share. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 20260.24 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
RBKB is a small-bank execution story, not yet a proven durable compounder. Its long-term thesis is in a watch state: management has made progress on deposits, interest income, and credit quality, while recent financial performance remains weak.
The valuation evidence is mixed: RBKB is described as cheap versus peers, while the peer premium measure points the other way. The expectations gap is negative, and the priced-in assessment says the fragility is justified by weak execution quality, not by a broader stack of expensive valuation and turbulent conditions.
Near term, deposit and interest-income growth support management’s franchise expansion focus, and past-due loans and net charge-offs have improved. The conversion is complete, but earnings quality is fragile and recent performance sits well below its industry cohort; a guidance cut or lower rates would add pressure.
Over the next few quarters, the thesis hinges on whether management can turn deposit growth and improved credit measures into steadier financial performance. A guidance cut or rate cuts are unfavorable scenarios, while continued earnings strength and higher guidance from sector bellwethers could support sector momentum.
For the next 1 to 3 years, RBKB has evidence of operational progress, but the mixed signal, weak recent results, and elevated risk leave the long-term thesis dependent on sustained execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Rhinebeck Bancorp, Inc.'s published investment case. The stated target is Completion and integration of material agreements in 2026. |
| Improving |
| Failure to complete or integrate material M&A deals in 2026 |
Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Quarterly net income near $2.2M to $2.3M | It maintains consistent net income around $2.2M to $2.3M quarterly. | Intact | Net income falls below $2.2M in any quarter | Net income: $2.616M FY2026-Q2; GAAP. Published target: Net income >= $2.2M per quarter. Target period is not explicitly aligned with this observation. Aug 13, 20262,616,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.